CN114958736B - 乳牙牙髓干细胞凋亡囊泡的制备方法和应用 - Google Patents
乳牙牙髓干细胞凋亡囊泡的制备方法和应用 Download PDFInfo
- Publication number
- CN114958736B CN114958736B CN202210575514.4A CN202210575514A CN114958736B CN 114958736 B CN114958736 B CN 114958736B CN 202210575514 A CN202210575514 A CN 202210575514A CN 114958736 B CN114958736 B CN 114958736B
- Authority
- CN
- China
- Prior art keywords
- hdpsc
- apovs
- gel
- dental pulp
- vesicle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000006907 apoptotic process Effects 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 210000004489 deciduous teeth Anatomy 0.000 title claims abstract description 10
- 210000000130 stem cell Anatomy 0.000 title abstract description 15
- 210000003074 dental pulp Anatomy 0.000 claims abstract description 42
- 230000001640 apoptogenic effect Effects 0.000 claims abstract description 15
- 230000001939 inductive effect Effects 0.000 claims abstract description 10
- 238000012258 culturing Methods 0.000 claims abstract description 8
- 210000005258 dental pulp stem cell Anatomy 0.000 claims abstract description 4
- HKSZLNNOFSGOKW-UHFFFAOYSA-N ent-staurosporine Natural products C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1C1CC(NC)C(OC)C4(C)O1 HKSZLNNOFSGOKW-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229920001992 poloxamer 407 Polymers 0.000 claims abstract description 4
- HKSZLNNOFSGOKW-FYTWVXJKSA-N staurosporine Chemical compound C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1[C@H]1C[C@@H](NC)[C@@H](OC)[C@]4(C)O1 HKSZLNNOFSGOKW-FYTWVXJKSA-N 0.000 claims abstract description 4
- CGPUWJWCVCFERF-UHFFFAOYSA-N staurosporine Natural products C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1C1CC(NC)C(OC)C4(OC)O1 CGPUWJWCVCFERF-UHFFFAOYSA-N 0.000 claims abstract description 4
- 210000004027 cell Anatomy 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 18
- 239000000243 solution Substances 0.000 claims description 10
- 239000002245 particle Substances 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 7
- 230000017423 tissue regeneration Effects 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 6
- 102000029816 Collagenase Human genes 0.000 claims description 5
- 108060005980 Collagenase Proteins 0.000 claims description 5
- 229960002424 collagenase Drugs 0.000 claims description 5
- 230000029087 digestion Effects 0.000 claims description 5
- 239000007853 buffer solution Substances 0.000 claims description 4
- 239000012634 fragment Substances 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 239000013049 sediment Substances 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 238000002955 isolation Methods 0.000 claims description 2
- 230000008929 regeneration Effects 0.000 abstract description 23
- 238000011069 regeneration method Methods 0.000 abstract description 23
- 238000010171 animal model Methods 0.000 abstract description 6
- 208000007147 dental pulp necrosis Diseases 0.000 abstract description 5
- 238000011269 treatment regimen Methods 0.000 abstract description 2
- 239000000284 extract Substances 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 description 39
- 210000004262 dental pulp cavity Anatomy 0.000 description 31
- 230000000694 effects Effects 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 238000011282 treatment Methods 0.000 description 8
- 241001247437 Cerbera odollam Species 0.000 description 6
- 230000002792 vascular Effects 0.000 description 6
- 241000282465 Canis Species 0.000 description 5
- 238000011065 in-situ storage Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 210000004746 tooth root Anatomy 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000001172 regenerating effect Effects 0.000 description 4
- 230000000250 revascularization Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 241000699660 Mus musculus Species 0.000 description 3
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 3
- 230000000975 bioactive effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000007408 cone-beam computed tomography Methods 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 210000004268 dentin Anatomy 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 210000004283 incisor Anatomy 0.000 description 3
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 3
- 238000011580 nude mouse model Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 230000021749 root development Effects 0.000 description 3
- 238000011476 stem cell transplantation Methods 0.000 description 3
- 210000003556 vascular endothelial cell Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000033115 angiogenesis Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 2
- 238000002659 cell therapy Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 210000001808 exosome Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000011502 immune monitoring Methods 0.000 description 2
- 238000003125 immunofluorescent labeling Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- 230000007310 pathophysiology Effects 0.000 description 2
- 229960001412 pentobarbital Drugs 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241001391944 Commicarpus scandens Species 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 201000004328 Pulpitis Diseases 0.000 description 1
- 206010037464 Pulpitis dental Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 210000003464 cuspid Anatomy 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000003076 paracrine Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000009168 stem cell therapy Methods 0.000 description 1
- 238000009580 stem-cell therapy Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 238000011277 treatment modality Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0664—Dental pulp stem cells, Dental follicle stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
- A61L27/3865—Dental/periodontal tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/12—Materials or treatment for tissue regeneration for dental implants or prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Developmental Biology & Embryology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210575514.4A CN114958736B (zh) | 2022-05-25 | 2022-05-25 | 乳牙牙髓干细胞凋亡囊泡的制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210575514.4A CN114958736B (zh) | 2022-05-25 | 2022-05-25 | 乳牙牙髓干细胞凋亡囊泡的制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114958736A CN114958736A (zh) | 2022-08-30 |
CN114958736B true CN114958736B (zh) | 2024-06-18 |
Family
ID=82956483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210575514.4A Active CN114958736B (zh) | 2022-05-25 | 2022-05-25 | 乳牙牙髓干细胞凋亡囊泡的制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114958736B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114525244A (zh) * | 2022-02-15 | 2022-05-24 | 中南大学 | 一种牙周牙髓联合病变组织中间充质干细胞的焦亡产物在疾病发生发展中的机制研究方法 |
CN115820548B (zh) * | 2022-12-12 | 2023-10-27 | 北京大学口腔医学院 | 一种动物组织来源的凋亡囊泡的制备方法及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106659740A (zh) * | 2014-08-08 | 2017-05-10 | 南加州大学阿尔弗雷德·E·曼生物医学工程研究所 | 凋亡小体 |
CN114224917A (zh) * | 2021-12-23 | 2022-03-25 | 中国人民解放军空军军医大学 | 间充质干细胞凋亡微囊泡联合水凝胶在制备哺乳动物皮肤修复产品中的应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113559124B (zh) * | 2021-08-10 | 2023-06-13 | 四川大学 | 间充质干细胞凋亡小体在制备治疗骨缺损的药物中的应用 |
CN113943705B (zh) * | 2021-11-01 | 2023-09-19 | 北京大学口腔医学院 | 一种凋亡微囊泡及其制备方法和应用 |
-
2022
- 2022-05-25 CN CN202210575514.4A patent/CN114958736B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106659740A (zh) * | 2014-08-08 | 2017-05-10 | 南加州大学阿尔弗雷德·E·曼生物医学工程研究所 | 凋亡小体 |
CN114224917A (zh) * | 2021-12-23 | 2022-03-25 | 中国人民解放军空军军医大学 | 间充质干细胞凋亡微囊泡联合水凝胶在制备哺乳动物皮肤修复产品中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN114958736A (zh) | 2022-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114958736B (zh) | 乳牙牙髓干细胞凋亡囊泡的制备方法和应用 | |
US11369716B2 (en) | Reparative cell isolation and delivery | |
AU2011358695B2 (en) | Method for producing regenerative organ primordium provided with guide for transplantation, composition containing regenerative organ primordium provided with guide for transplantation produced thereby, and method for transplanting regenerative organ primordium provided with guide for transplantation | |
JP6196217B2 (ja) | 筋線維断片を利用した筋組織再生 | |
JP2012107026A (ja) | 関節軟骨損傷治療用組成物 | |
CN102068318B (zh) | 生物牙根支架材料的构建方法 | |
Griffin et al. | The use of adipose stem cells in cranial facial surgery | |
CN101828937A (zh) | 一种利用组织工程脂肪再生技术进行整形美容的方法 | |
CN111388504B (zh) | 牙上皮细胞外泌体制备、外泌体植入物的制备及其应用 | |
CN1668732A (zh) | 用自体同源的成纤维细胞治疗 | |
CN112587729B (zh) | 一种骨修复材料 | |
Zhu et al. | Insights into the use of genetically modified decellularized biomaterials for tissue engineering and regenerative medicine | |
CN109182249B (zh) | 一种在体修复用细胞移植的支架材料的制备方法 | |
CN113621570A (zh) | 基于数字光学处理打印技术的组织工程牙髓及制备方法 | |
CN102178981B (zh) | 一种软骨修复支架材料的制备方法 | |
CN104587523A (zh) | 一种负载富集骨髓间充质干细胞的自固化磷酸钙骨水泥及制备方法 | |
CN110237302A (zh) | 一种关节软骨修复材料的制备方法-自体富血小板血浆结合透明质酸水凝胶 | |
CN101993853A (zh) | 注射式血管化脂肪组织及其构建方法 | |
CN104815356A (zh) | 一种中空开放明胶细胞微载体及其制备方法和应用 | |
CN105266916A (zh) | 一种以再利用为目的离体牙处理及储存的方法 | |
Qian et al. | Effect of acellular nerve scaffold containing human umbilical cord-derived mesenchymal stem cells on nerve repair and regeneration in rats with sciatic nerve defect | |
CN112618798B (zh) | 一种骨修复材料的制备方法 | |
CN109758261A (zh) | 一种立体肌腱生物补片及其制备方法和用途 | |
Kanwal et al. | The current status of stem cell regeneration in intra oral applications—a systematic review | |
CN101530632A (zh) | 一种组织工程化肝移植物的构建与植入方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240515 Address after: Room 0292, 2nd Floor, Building 21, Second District, Tiantong Zhongyuan, Dongxiaokou Town, Changping District, Beijing 102200 Applicant after: Guo Xiaohe Country or region after: China Applicant after: Feng Yuan Address before: Room 0292, 2nd Floor, Building 21, Second District, Tiantong Zhongyuan, Dongxiaokou Town, Changping District, Beijing 102200 Applicant before: Wang Juan Country or region before: China |
|
GR01 | Patent grant | ||
GR01 | Patent grant |